These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31333200)

  • 61. Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.
    Neilan AM; Landovitz RJ; Le MH; Grinsztejn B; Freedberg KA; McCauley M; Wattananimitgul N; Cohen MS; Ciaranello AL; Clement ME; Reddy KP; Hyle EP; Paltiel AD; Walensky RP
    Ann Intern Med; 2022 Apr; 175(4):479-489. PubMed ID: 35099992
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Individual and Health System Factors for Uptake of Pre-exposure Prophylaxis Among Young Black and Latino Gay Men.
    Andrade EA; Stoukides G; Santoro AF; Karasz A; Arnsten J; Patel VV
    J Gen Intern Med; 2023 Sep; 38(12):2768-2774. PubMed ID: 37429976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts.
    Cahill S; Taylor SW; Elsesser SA; Mena L; Hickson D; Mayer KH
    AIDS Care; 2017 Nov; 29(11):1351-1358. PubMed ID: 28286983
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison between daily and on-demand PrEP (pre-exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open-label, crossover trial.
    Kwan TH; Lui GCY; Lam TTN; Lee KCK; Wong NS; Chan DPC; Lee SS
    J Int AIDS Soc; 2021 Sep; 24(9):e25795. PubMed ID: 34473402
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
    JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Brief Report: Group Sex Among Men Who Have Sex With Men in the Era of PrEP: A Cross-Sectional Study.
    Phillips TR; Fairley CK; Bradshaw CS; Hocking JS; Choi EPH; Ong JJ; Tabesh M; Maddaford K; Chow EPF
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):e23-e27. PubMed ID: 33093332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enrolment characteristics associated with retention among HIV negative Kenyan gay, bisexual and other men who have sex with men enrolled in the Anza Mapema cohort study.
    Kunzweiler C; Bailey RC; Okall DO; Graham SM; Mehta SD; Otieno-Nyunya B; Djomand G; Otieno FO
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25598. PubMed ID: 33000884
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal (Actuel sur Rue).
    Lebouché B; Engler K; Machouf N; Lessard D; Thomas R
    HIV Med; 2016 Feb; 17(2):152-8. PubMed ID: 26177691
    [TBL] [Abstract][Full Text] [Related]  

  • 69. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis.
    Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN
    Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brief Report: Refusal of Daily Oral PrEP: Implementation Considerations and Reported Likelihood of Using Various HIV Prophylaxis Products in a Diverse Sample of MSM.
    Mansergh G; Kota KK; Carnes N; Gelaude D
    J Acquir Immune Defic Syndr; 2023 Mar; 92(3):212-216. PubMed ID: 36442153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.
    John SA; Rendina HJ; Grov C; Parsons JT
    PLoS One; 2017; 12(12):e0189794. PubMed ID: 29281688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada.
    Grace D; Gaspar M; Wells A; Sinno J; Daroya E; Montess M; Hull M; Lachowsky NJ; Tan DHS
    AIDS Patient Care STDS; 2023 Jun; 37(6):306-315. PubMed ID: 37195728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Barriers to HIV pre-exposure prophylaxis among African, Caribbean and Black men in Toronto, Canada.
    Zhabokritsky A; Nelson LE; Tharao W; Husbands W; Sa T; Zhang N; Thomas-Pavanel J; Baidoobonso S; Kaul R
    PLoS One; 2019; 14(3):e0213740. PubMed ID: 30925582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK.
    O'Halloran C; Croxford S; Mohammed H; Gill ON; Hughes G; Fifer H; Allen H; Owen G; Nutland W; Delpech V; Saunders JM
    Sex Transm Infect; 2021 Sep; 97(6):429-433. PubMed ID: 33082235
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial.
    Wang H; Wang Z; Huang X; Chen Y; Wang H; Cui S; Zhang J; Chu Z; Hu Q; Ding H; Qian H; Zou H; Tang W; Gao Y; Jin X; Liu Z; Zhang L; Zhao J; He X; Jiang Y; Geng W; Xu J; Shang H;
    JAMA Netw Open; 2022 Feb; 5(2):e2148782. PubMed ID: 35171258
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Daily use of HIV pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Spain: Prevalence and associated factors.
    Moreno-García S; Belza MJ; Iniesta C; González-Recio P; Palma D; Sordo L; Pulido J; Guerras JM
    Med Clin (Barc); 2024 Feb; 162(3):95-102. PubMed ID: 37813725
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adolescent Health Providers' Willingness to Prescribe Pre-Exposure Prophylaxis (PrEP) to Youth at Risk of HIV Infection in the United States.
    Hart-Cooper GD; Allen I; Irwin CE; Scott H
    J Adolesc Health; 2018 Aug; 63(2):242-244. PubMed ID: 29843969
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sociodemographic Characteristics of HIV Pre-Exposure Prophylaxis Use and Reasons for Nonuse Among Gay, Bisexual, and Other Men Who Have Sex with Men from Three US Cities.
    Kota KK; Mansergh G; Stephenson R; Hirshfield S; Sullivan P
    AIDS Patient Care STDS; 2021 May; 35(5):158-166. PubMed ID: 33901403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.